3rd Immunogenicity and Immunotoxicity Conference on January 29-30, 2015 in San Diego, CA
The conference will cover important progress made in the areas of therapeutic protein immunogenicity and immunotoxicity evaluation such as protein aggregation, clinical relevance and assessment of immunogenicity, mitigation of immunogenicity-related risks, biosimilar development, and immunotoxicity evaluation strategies.
Guests will get an up-to-date understanding of the mechanisms and consequences of protein aggregation and insights on how to prosecute state-of-the-art assessment of the clinical immunogenicity of therapeutic proteins.
Sessions for the 2015 program:
I. Immunotoxicity Evaluation of Novel Drug Candidates II. Immunotoxicity and Drug Hypersensitivity III. Immunogenicity Assessment for Biosimilars IV. Immunogenicity Assessment for Peptide Therapeutics V. Protein Aggregation, Biological Activity and Immunogenicity VI. Computational Methods for Immunogenicity Evaluation
